Phytochemical Screening and Antibacterial Activity of Lignosus rhinocerotis (Cooke) Ryvarden Grown in Open Field and Indoor

Lignosus rhinocerotis (Cooke) Ryvarden, known as tiger milk mushroom, is a rare and valuable medicinal mushroom that is widely used throughout Southeast Asia and South China for treating several ailments. This study was conducted to screen the phytochemicals present in L. rhinocerotis (Cooke) Ryvarden sclerotium grown from two different environments, open field and indoor, and evaluate the antibacterial activity. In this study, phytochemical screening of ethyl acetate and methanolic extract of L. rhinocerotis (Cooke) Ryvarden sclerotium were done using various chemical tests to identify the compounds present in the extracts. All the extracts were then tested for antibacterial activity against three different bacteria including Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa at the concentrations of 20 and 30 mg/mL using disc diffusion method. Based on the phytochemical screening result, extracts of L. rhinocerotis (Cooke) Ryvarden demonstrated the presence of steroids, terpenoids, alkaloids, and flavonoids. The antibacterial assays revealed that the ethyl acetate extracts from open field and indoor cultivations exhibited moderate activities against S. aureus at 30 mg/mL with the values of the inhibition zone being 13.3 ± 0.67 mm and 11.0 ± 0.58 mm, respectively.

Bioactive components of mushrooms: Processing effects and health benefits

Mushrooms have been recognized for their culinary attributes for long and were relished in the most influential civilizations in history. Currently, they are the focus of renewed research because of their therapeutic abilities. Nutritional benefits from mushrooms are in the form of a significant source of essential proteins, dietary non-digestible carbohydrates, unsaturated fats, minerals, as well as various vitamins, which have enhanced its consumption, and also resulted in the development of various processed mushroom products. Mushrooms are also a crucial ingredient in traditional medicine for their healing potential and curative properties. The literature on the nutritional, nutraceutical, and therapeutic potential of mushrooms, and their use as functional foods for the maintenance of health was reviewed, and the available literature indicates the enormous potential of the bioactive compounds present in mushrooms. Future research should be focused on the development of processes to retain the mushroom bioactive components, and valorization of waste generated during processing. Further, the mechanisms of action of mushroom bioactive components should be studied in detail to delineate their diverse roles and functions in the prevention and treatment of several diseases.

Synthesized 2-Trifluoromethylquinazolines and Quinazolinones Protect BV2 and N2a Cells against LPS- and H2O2-induced Cytotoxicity

BACKGROUND

Microglia are associated with neuroinflammation, which play a key role in the pathogenesis of neurodegenerative diseases. It has been reported that some quinazolines and quinazolinones possess anti-inflammatory properties. However, the pharmacological properties of certain quinazoline derivatives are still unknown.

OBJECTIVE

The antioxidant, cytotoxic, and protective effects of a series of synthesized 2- trifluoromethylquinazolines (2, 4, and 5) and quinazolinones (6-8) in lipopolysaccharide (LPS)- murine microglia (BV2) and hydrogen peroxide (H₂O₂)-mouse neuroblastoma-2a (N2a) cells were investigated.

METHOD

The antioxidant activity of synthesized compounds was evaluated with ABTS and DPPH assays. The cytotoxic activities were determined by MTS assay in BV2 and N2a cells. The production of nitric oxide (NO) in LPS-induced BV2 microglia cells was quantified.

RESULTS

The highest ABTS and DPPH scavenging activities were observed for compound 8 with 87.7% of ABTS scavenge percentage and 54.2% DPPH inhibition. All compounds were noncytotoxic in BV2 and N2a cells at 5 and 50 μg/mL. The compounds which showed the highest protective effects in LPS-induced BV2 and H₂O₂-induced N2a cells were 5 and 7. All tested compounds, except 4, also reduced NO production at concentrations of 50 μg/mL. The quinazolinone series 6-8 exhibited the highest percentage of NO reduction, ranging from 38 to 60%. Compounds 5 and 8 possess balanced antioxidant and protective properties against LPS- and H₂O₂-induced cell death, thus showing great potential to be developed into anti-inflammatory and neuroprotective agents.

CONCLUSION

Compounds 5 and 7 were able to protect the BV2 and N2a cells against LPS and H₂O₂ toxicity, respectively, at a low concentration (5 μg/mL). Compounds 6-8 showed potent reduction of NO production in BV2 cells.